MYOS RENS Technology Inc. (MYOS) insider have most recently took part in a trading activity. On Dec 21, 2017 Mannello Joseph, CEO bought 20,336 shares having total worth of $29,691 at the price of $1.46 per share, following the transaction a total of 274,765 shares owned by Mannello Joseph. Before this latest buy, Mannello Joseph purchased MYOS at 2 other times during the past twelve months, for a total investment of $84,211 at an average of $1.33 per share.
The stock has experienced a total of 2 insider trades in the past three months. These trades include 2 buy trades. Furthermore, over the past 12 months , the stock was traded 2 times by insiders. an employee of the company was the buyer in 2 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Shares of MYOS RENS Technology Inc. (MYOS) traded down 3.54% on Dec 22, 2017, hitting $1.39. 47,093 shares of the company’s stock traded hands. MYOS RENS Technology Inc. has a 52 week low of $1.14 and a 52 week high of $6.82. The company’s market cap is $9 million.
MYOS RENS Technology Inc. (MYOS) last announced its earnings results on Nov 14, 2017. The company reported -0.13 earnings per share (EPS) for the quarter. The company had revenue of $0 million for the quarter During the same quarter in the previous year, the company posted -0.17 earnings per share. The company’s revenue for the quarter was up 310% on a year-over-year basis.
|earnings per share||-0.13||-0.39||-0.30||-0.50||0.00||-0.18|
MYOS Corp is engaged in the discovery, development and commercialization of nutritional supplements, functional foods, therapeutic products and other technologies aimed at maintaining or improving the health and performance of muscle tissue.
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018